DOSSIER · 13F Holders · Q1 2026High-convictionMulti-bagger

ENTRADA THERAPEUTICS INC

2 institutions still hold ENTRADA THERAPEUTICS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 29384C908·2 13F holders·last filed Mar 31, 2026

Market cap

—

▲ 6.7%

vs prior quarter

13F value held

$22M

71.0% inst. owned

of float

Holders

+64 QoQ

filers reporting

Activity

+46 / −42

+781 added · −702 reduced

this quarter

Concentration

100.00%

Merck & Co., Inc. #1

top holder share

AI Holders Summary · Q1 2026

2 institutions reported ENTRADA THERAPEUTICS INC in Q1 2026. Merck & Co., Inc. leads at 100.0% of the visible book. +64 net new institutions vs prior quarter — accumulation reading.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter

Merck & Co., Inc.

CIK 0000310158

$22M1.7M6.28%Q1 2026 02

CONCOURSE FINANCIAL GROUP SECURITIES, INC.

CIK 0000752798

$00—Q2 2025